Iambic Therapeutics, a biotechnology company developing novel therapeutics using its unique AI-driven discovery platform, announced that the first patient has been dosed in its...
Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the publication of a new study featuring Lunit SCOPE IO, Lunit's...
Biodesix, Inc., a leading diagnostic solutions company with a focus in lung diseases, announced that it has entered into a new master collaborative research...
A2 Biotherapeutics, Inc., a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to address the high unmet needs in cancer, announced the appointment...
VRG50635 is one of the first clinical-stage drugs discovered and developed entirely using an AI-powered platform
Verge Genomics, a leading clinical-stage biotechnology company, and Ferrer,...
Profluent, an AI-first protein design company, announced the close of additional funding to bring the total raised to $44M. The $35M financing was led...
Acquisition of MotionHall reinforces strategy to lead market-specific solutions, including workflows and expert services fuelled by industry vertical AI
Clarivate Plc a leading global provider of...